Deep learning finds an ECG biomarker for sudden cardiac death
The Nature paper, published online on 2026-06-24, reports a deep-learning ECG biomarker evaluated retrospectively in Swedish data and external US and Taiwanese datasets. Its high-risk group comprised 2.2% of the sample and had a 7.0% annual sudden-cardiac-death rate, versus 4.6% for reduced LVEF; 86.1% were not flagged by LVEF. Among high-risk patients with defibrillators, sudden cardiac death was 54.4% lower than model-expected, an observational association subject to confounding and not proof of benefit.
Technology: Deep learning ECG model with a generative ECG waveform model for visualization
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Existing Swedish ECG/death-certificate data, a held-out lockbox created before analysis, external US ventricular-arrhythmia and Taiwanese arrhythmic-arrest evaluations; observational defibrillator associations.
- Still unknown: Main paper reviewed; supplementary attachments not read. The authors explicitly identify residual confounding and the need for randomized testing of defibrillator benefit in model-high-risk patients.
- AI role: Deep learning model discovered the predictive ECG waveform pattern; generative model used to visualize it.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.1038%2Fs41586-026-10674-6%22&resultType=core&format=json · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13323061/fullTextXML
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.